Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been proved having a better safety profile compared to platinum-based chemotherapy and have demonstrated encouraging anti-tumor therapeutic effects for patients with metastatic urothelial carcinoma (mUC). However, few studies have evaluated the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Kangxin, Yu, Chenhao, Wang, Huailan, Zhu, Shibin, Yu, Shicheng, Li, Gonghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189380/
https://www.ncbi.nlm.nih.gov/pubmed/37206016
http://dx.doi.org/10.1016/j.heliyon.2023.e15813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189380/
https://www.ncbi.nlm.nih.gov/pubmed/37206016
http://dx.doi.org/10.1016/j.heliyon.2023.e15813

Ejemplares similares